Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis
暂无分享,去创建一个
[1] R. Treisman,et al. The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF , 1995, Cell.
[2] A. Bretscher,et al. ERM proteins and merlin: integrators at the cell cortex , 2002, Nature Reviews Molecular Cell Biology.
[3] J. Segall,et al. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. , 2000, Cancer research.
[4] J. J. Gibson,et al. Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] I. Fidler,et al. Critical determinants of cancer metastasis: rationale for therapy , 1999, Cancer Chemotherapy and Pharmacology.
[6] K. Kaibuchi,et al. Formation of Actin Stress Fibers and Focal Adhesions Enhanced by Rho-Kinase , 1997, Science.
[7] Manuel Hidalgo,et al. Development of matrix metalloproteinase inhibitors in cancer therapy. , 2002, Hematology/oncology clinics of North America.
[8] J. Zavadil,et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. , 2002, Cancer research.
[9] D. Schlaepfer,et al. v-Src SH3-enhanced Interaction with Focal Adhesion Kinase at β1 Integrin-containing Invadopodia Promotes Cell Invasion* , 2002, The Journal of Biological Chemistry.
[10] Shuh Narumiya,et al. An essential part for Rho–associated kinase in the transcellular invasion of tumor cells , 1999, Nature Medicine.
[11] Shuh Narumiya,et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.
[12] A. Ridley. Rho GTPases and cell migration. , 2001, Journal of cell science.
[13] Alexis Gautreau,et al. Ezrin Is an Effector of Hepatocyte Growth Factor–mediated Migration and Morphogenesis in Epithelial Cells , 1997, The Journal of cell biology.
[14] L. Liotta,et al. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.
[15] S. Hirohashi,et al. Inhibition of intrahepatic metastasis of human hepatocellular carcinoma by Rho‐associated protein kinase inhibitor Y‐27632 , 2001, Hepatology.
[16] Kozo Kaibuchi,et al. Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.
[17] O. Weiner,et al. PIP3, PIP2, and cell movement--similar messages, different meanings? , 2001, Developmental cell.
[18] E. Sahai,et al. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I , 2001, Nature Cell Biology.
[19] T. Matsui,et al. Rho-dependent and -independent activation mechanisms of ezrin/radixin/moesin proteins: an essential role for polyphosphoinositides in vivo. , 2002, Journal of cell science.
[20] A. Ridley,et al. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling , 1992, Cell.
[21] K. Fujisawa,et al. p160ROCK, a Rho‐associated coiled‐coil forming protein kinase, works downstream of Rho and induces focal adhesions , 1997, FEBS letters.
[22] Kenneth M. Yamada,et al. Cell interactions with three-dimensional matrices. , 2002, Current opinion in cell biology.
[23] B. Kaina,et al. Rho GTPases are over‐expressed in human tumors , 1999, International journal of cancer.
[24] Peter Friedl,et al. Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.
[25] E. Sahai,et al. ROCK and Dia have opposing effects on adherens junctions downstream of Rho , 2002, Nature Cell Biology.
[26] E. Sahai,et al. Cross‐talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility , 2001, The EMBO journal.
[27] Eric S. Lander,et al. Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.
[28] G. Kroemer,et al. Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. , 2002, Cancer research.
[29] J. Thiery. Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.
[30] S. Merajver,et al. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] S. Narumiya,et al. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. , 1998, British Journal of Cancer.
[32] Julian Downward,et al. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell–matrix and cell–cell interaction , 1999, Current Biology.
[33] P. Argos,et al. β-COP, a 110 kd protein associated with non-clathrin-coated vesicles and the golgi complex, shows homology to β-adaptin , 1991, Cell.